BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7216093)

  • 1. [Bioavailability of various iron preparations following oral medication].
    Heilmann E; Keim G
    Fortschr Med; 1980 Dec; 98(47-48):1871-4. PubMed ID: 7216093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of bi- and trivalent oral iron preparations. Investigations of iron absorption by postabsorption serum iron concentrations curves.
    Dietzfelbinger H
    Arzneimittelforschung; 1987 Jan; 37(1A):107-12. PubMed ID: 3566864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigations of the bioavailability of iron from bi- and trivalent iron salts (author's transl)].
    Dietzfelbinger H; Kaboth W
    Med Klin; 1977 Apr; 72(15):654-9. PubMed ID: 853979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of trivalent iron in oral iron preparations. Therapeutic efficacy and iron absorption from simple ferric compounds and high- or low-molecular weight ferric hydroxide-carbohydrate complexes.
    Heinrich HC
    Arzneimittelforschung; 1975 Mar; 25(3):420-6. PubMed ID: 1174047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability and therapeutic efficacy of bivalent and trivalent iron preparations.
    Kaltwasser JP; Werner E; Niechzial M
    Arzneimittelforschung; 1987 Jan; 37(1A):122-9. PubMed ID: 3566867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of iron deficiency and replacement.
    Török K
    Ther Hung; 1991; 39(2):71-4. PubMed ID: 1948780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral iron therapy. Bioavailability and therapeutic effectiveness of ferrous iron in effervescent tablets in posthemorrhagic iron deficiency anemia].
    Kaltwasser JP; Schwarz-van de Sand W
    Dtsch Med Wochenschr; 1989 Aug; 114(31-32):1188-95. PubMed ID: 2666080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of bio-availability, antianaemic efficacy, tolerance and drug costs in oral iron(II) and iron(III) preparations (author's transl)].
    Dietzfelbinger H; Kaboth W
    Med Klin; 1979 Nov; 74(48):1818-24. PubMed ID: 395435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of bioavailability of oral iron preparations.
    Gupta KC; Paul T; Mehta JM; Desai NK; Sanghvi B; Sheth UK
    J Postgrad Med; 1976 Apr; 22(2):94-9. PubMed ID: 802126
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative assessment of the bioavailability, efficacy and safety of a modified-release (MR) carbonyl iron tablet and oral conventional iron preparation in adult Indian patients with nutritional iron deficiency anaemia.
    Adsul BB; Desai A; Gawde A; Baliga V
    J Indian Med Assoc; 2005 Jun; 103(6):338-42. PubMed ID: 16225161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bioavailability of iron in oral iron preparations. Principles of duration and dosage (author's transl)].
    Heinrich HC; Gabbe EE
    MMW Munch Med Wochenschr; 1979 Aug; 121(35):1104-8. PubMed ID: 114773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bioavailability of Ce-Ferro forte. Comparative iron load test (author's transl)].
    Richter E; Schmitt B; Zilly W
    Med Klin; 1978 Aug; 73(34):1171-5. PubMed ID: 683118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron pharmacokinetics after administration of ferric-hydroxide-polymaltose complex in rats.
    Geisser P; Müller A
    Arzneimittelforschung; 1984; 34(11):1560-9. PubMed ID: 6543131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative evaluation of the effectiveness of peroral treatment of patients with chronic posthemorrhagic anemia with iron-containing preparations].
    Bokarev IN; Andreeva VK; Astashenko NA; Gol'tiakova TV; Ershov VI
    Klin Med (Mosk); 1975 Nov; 53(11):110-3. PubMed ID: 1223501
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioavailability of iron from oral ferric polymaltose in humans.
    Nielsen P; Gabbe EE; Fischer R; Heinrich HC
    Arzneimittelforschung; 1994 Jun; 44(6):743-8. PubMed ID: 8053973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopharmaceutical evaluation of ferrous salts in form of oral long-acting tablets.
    Krzyśko K; Bokowski W; Wichliński LM
    Pol J Pharmacol Pharm; 1984; 36(1):73-7. PubMed ID: 6462964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of iron deficiency with orally administered delayed-action ferrous sulfate and mucoproteose].
    Schindler VH; Bielesz G
    Wien Med Wochenschr; 1975 Mar; 125(11):173-6. PubMed ID: 1130090
    [No Abstract]   [Full Text] [Related]  

  • 18. [Resorption of oral iron preparations].
    Heinrich HC; Führ J
    Med Welt; 1980 Jul; 31(29-30):1104-5. PubMed ID: 7412541
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioavailability of iron in oral ferrous sulfate preparations in healthy volunteers.
    Walker SE; Paton TW; Cowan DH; Manuel MA; Dranitsaris G
    CMAJ; 1989 Sep; 141(6):543-7. PubMed ID: 2776093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor clinical response to enteric-coated iron preparations.
    Rudinskas L; Paton TW; Walker SE; Dotten DA; Cowan DH
    CMAJ; 1989 Sep; 141(6):565-6. PubMed ID: 2776097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.